LRPPRC is well known as a regulator of mitochondrial function in cancer progression that acts by interacting with mitochondrial-related proteins, including Beclin-1 and Bcl-2, thus activating PI3KCIII (Zou et al., 2013; Zou et al., 2014). The gene discussed is BECN1; the disease is cancer.